Pregnancy in Inflammatory Bowel Disease: Experience of a Chilean cohort.

Embarazo en enfermedad inflamatoria intestinal: experiencia en una cohorte chilena.
Colitis ulcerosa Consejo preconcepcional Crohńs disease Embarazo Enfermedad de Crohn Enfermedad inflamatoria intestinal Inflammatory bowel disease Preconception counselling Pregnancy Ulcerative colitis

Journal

Gastroenterologia y hepatologia
ISSN: 0210-5705
Titre abrégé: Gastroenterol Hepatol
Pays: Spain
ID NLM: 8406671

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 19 06 2020
revised: 12 08 2020
accepted: 25 08 2020
entrez: 22 3 2021
pubmed: 23 3 2021
medline: 5 11 2021
Statut: ppublish

Résumé

In inflammatory bowel disease (IBD) a high percentage of women are diagnosed during their reproductive age. IBD in remission is the ideal scenario when planning a pregnancy. To describe the clinical characteristics of pregnancy/newborn and assess disease activity at the time of conception and throughout the pregnancy in patients with IBD treated at a tertiary centre in Chile. We retrospectively reviewed women diagnosed with IBD who were pregnant or delivered between 2017 and 2020. Demographic, clinical, obstetric and delivery data were obtained from the IBD registry, approved by the local IRB. Descriptive statistics and association tests were performed (χ2, p ≤ 0.05). Sixty women with IBD were included. At the beginning of pregnancy, 21 (35%) had active disease and 39 (65%) were in remission. Of those with active disease, 16 (66%) remained active and 6 had spontaneous abortions. In those who were in remission, 26 (69%) remained in this condition. Nine patients (15%) discontinued treatment, and 6 of these had inflammatory activity during pregnancy. Preconception counselling was performed in 23 of the 60 patients, being higher in the group that remained in remission during pregnancy (65% vs. 35%, p = 0.02). Patients who had a flare during pregnancy had more probability of preterm birth (<37 weeks) and newborn with lower weight compared with the group that always remained in remission (89% vs. 74%, p = 0.161) and (2.885 vs 3.370 g; p = 0.0014). Remission presents better outcomes in pregnancy and preconception counselling would allow a better IBD control during pregnancy.

Sections du résumé

BACKGROUND BACKGROUND
In inflammatory bowel disease (IBD) a high percentage of women are diagnosed during their reproductive age. IBD in remission is the ideal scenario when planning a pregnancy.
AIMS OBJECTIVE
To describe the clinical characteristics of pregnancy/newborn and assess disease activity at the time of conception and throughout the pregnancy in patients with IBD treated at a tertiary centre in Chile.
METHODS METHODS
We retrospectively reviewed women diagnosed with IBD who were pregnant or delivered between 2017 and 2020. Demographic, clinical, obstetric and delivery data were obtained from the IBD registry, approved by the local IRB. Descriptive statistics and association tests were performed (χ2, p ≤ 0.05).
RESULTS RESULTS
Sixty women with IBD were included. At the beginning of pregnancy, 21 (35%) had active disease and 39 (65%) were in remission. Of those with active disease, 16 (66%) remained active and 6 had spontaneous abortions. In those who were in remission, 26 (69%) remained in this condition. Nine patients (15%) discontinued treatment, and 6 of these had inflammatory activity during pregnancy. Preconception counselling was performed in 23 of the 60 patients, being higher in the group that remained in remission during pregnancy (65% vs. 35%, p = 0.02). Patients who had a flare during pregnancy had more probability of preterm birth (<37 weeks) and newborn with lower weight compared with the group that always remained in remission (89% vs. 74%, p = 0.161) and (2.885 vs 3.370 g; p = 0.0014).
CONCLUSION CONCLUSIONS
Remission presents better outcomes in pregnancy and preconception counselling would allow a better IBD control during pregnancy.

Identifiants

pubmed: 33745519
pii: S0210-5705(20)30320-4
doi: 10.1016/j.gastrohep.2020.08.005
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

277-285

Informations de copyright

Copyright © 2020 Elsevier España, S.L.U. All rights reserved.

Auteurs

Paulina Nuñez F (P)

Universidad de Chile, Facultad de Medicina Occidente, Hospital San Juan de Dios, Universidad de Chile, Santiago, Chile.

Rodrigo Quera (R)

Programa Enfermedad Inflamatoria Intestinal, Departamento Gastroenterología, Clínica Las Condes, Santiago, Chile. Electronic address: rquera@clc.cl.

Eduardo Sepúlveda (E)

Departamento de Ginecología y Obstetricia Universidad de Chile, Santiago, Chile.

Daniela Simian (D)

Dirección Académica, Departamento Gastroenterología, Clínica Las Condes, Santiago, Chile.

Gonzalo Pizarro (G)

Programa Enfermedad Inflamatoria Intestinal, Departamento Gastroenterología, Clínica Las Condes, Santiago, Chile.

Jaime Lubascher (J)

Programa Enfermedad Inflamatoria Intestinal, Departamento Gastroenterología, Clínica Las Condes, Santiago, Chile.

Lilian Flores (L)

Programa Enfermedad Inflamatoria Intestinal, Departamento Gastroenterología, Clínica Las Condes, Santiago, Chile.

Patricio Ibañez (P)

Programa Enfermedad Inflamatoria Intestinal, Departamento Gastroenterología, Clínica Las Condes, Santiago, Chile.

Carolina Figueroa (C)

Unidad de Coloproctología, Departamento de Cirugía, Clínica Las Condes, Santiago, Chile.

Udo Kronberg (U)

Unidad de Coloproctología, Departamento de Cirugía, Clínica Las Condes, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH